| Stage | J | % of rev | ORN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $4.1B | 100.00% | $256M | 100.00% | J ×15.91 |
| Gross profit | $811M | 19.89% | $33M | 12.94% | J +7.0pp |
| Operating income | $287M | 7.03% | $9M | 3.33% | J +3.7pp |
| Pre-tax income | $241M | 5.92% | $6M | 2.29% | J +3.6pp |
| Net income | $136M | 3.33% | $5M | 2.14% | J +1.2pp |
| Stage | J | ORN | Gap · A − B |
|---|---|---|---|
| Revenue | $4.1B100.00% | $256M100.00% | J ×15.91 |
| Gross profit | 19.89%$811M | 12.94%$33M | J +7.0pp |
| Operating income | 7.03%$287M | 3.33%$9M | J +3.7pp |
| Pre-tax income | 5.92%$241M | 2.29%$6M | J +3.6pp |
| Net income | 3.33% |
| 2.14%$5M |
| J +1.2pp |
No shared counterparties.